Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Sucampo Pharmaceuticals, Inc.    SCMP

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Manufactures pharmaceuticals and health care products

Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products.

It operates through the following geographic segments: Asia, the Americas, and Europe.

It offers Lubiprostone, which treats chronic constipation, chronic idiopathic constipation in adults, irritable bowel syndrome with constipation in adult women, and opiod-induced constipation in adults with chronic non-cancer pain.

The company was founded by Dr. Ryuji Ueno and Dr. Sachiko Kuno on December 5, 1996 and is headquartered in Rockville, MD.

Number of employees : 139 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Product Royalty74.1448.4%82.4835.9% +11.25%
Product Sales66.2843.3%128.8056% +94.33%
Research and Development10.206.7%12.845.6% +25.88%
Contract and Collaboration2.571.7%5.942.6% +131.44%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States95.7762.5%140.2461% +46.44%
Japan55.3736.1%83.1336.1% +50.13%
Rest of the World2.041.3%6.692.9% +227.75%
Managers
NameAgeSinceTitle
Peter S. Greenleaf, MBA472014Chairman & Chief Executive Officer
Peter P. Pfreundschuh MBA, CPA472017Chief Financial Officer
Peter Lichtlen MD, PhD492011Chief Medical Officer
Peter Alec Kiener, PhD642014Chief Scientific Officer
Maureen E. O'Connell, CPA552013Independent Director
John H. Johnson592014Lead Independent Director
Robert Jay Spiegel, MD662015Independent Director
Timothy P. Walbert502015Independent Director
Paul R. Edick622016Independent Director
Karen L. Smith MD, PhD492017Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 46,636,924 29,176,800 62.6% 227,266 0.5% 62.6%
Shareholders
NameEquities%
Ryuji Ueno, MD, PhD 9,080,059 19.5%
Sachiko Kuno, PhD 8,353,204 17.9%
BlackRock Fund Advisors 3,761,870 8.08%
Krensavage Asset Management LLC 2,833,416 6.09%
Linden Advisors LP 2,489,131 5.35%
LSV Asset Management 2,466,418 5.30%
Point72 Asset Management LP 1,863,435 4.00%
The Vanguard Group, Inc. 1,589,374 3.41%
Dimensional Fund Advisors LP 1,485,160 3.19%
Renaissance Technologies LLC 1,305,700 2.80%
Company contact information
Sucampo Pharmaceuticals, Inc.
805 King Farm Boulevard
Suite 550
Rockville, MD 20850

Phone : +1.301.961.3400
Fax : +1.301.961.3440
Web : www.sucampo.com
Sector Bio Therapeutic Drugs
Connections : Sucampo Pharmaceuticals, I
Biotechnology Innovation Organization
Chicagonext
The W2O Group
Horizon Pharmaceutical LLC
VirMedica, Inc.
Vicuron Pharmaceuticals, Inc.
Scholastic, Inc.
Sucampo AG
Cempra Pharmaceuticals, Inc.
The Arthritis Foundation
TetraGenetics, Inc.
Illinois Innovation Council
Plum Brook Advisors LLC
Gitbasic LLC
Spiegel Consultants, LLC
Cortendo AB
Resolve Therapeutics LLC
Numab AG
Cue Biopharma, Inc.
Illinois Biotechnology Industry Organization
FMH Swiss Medical Association
World Business Chicago
Swiss Association of Pharmaceutical Professionals, Inc.
MATTER Chicago
Avior Computing Corp.
Xeris Pharmaceuticals, Inc.
Weill Cornell Medical College
Iterum Therapeutics Ltd.
Hyperion Therapeutics, Inc.
Pharmaceutical Research & Manufacturers of America
Horizon Pharma USA, Inc.
3G Advisors LLC
NexImmune, Inc.
Maryland Venture Fund
Vidac Pharma Ltd.
© 2017 People , Fundamentals and Ownership